Patients with an ICD-10 diagnosis of bipolar disorder in remission were randomized , with stratification by age and gender , to receive 8 weekly erythropoietin ( 40,000 IU ) or saline ( sodium chloride [ NaCl ] , 0.9 % ) infusions in a double-blind , parallel-group design .